Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A lepidic gene signature predicts patient prognosis and sensitivity to immunotherapy in lung adenocarcinoma
Thinh T. Nguyen, Hyun‐Sung Lee, Bryan M. Burt, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Ferroptosis and circular RNAs: new horizons in cancer therapy.
Asif Ahmad Bhat, Neelima Kukreti, Muhammad Afzal, et al.
PubMed (2024) Vol. 23, pp. 570-599
Closed Access | Times Cited: 7
Clinical implications and molecular features of tertiary lymphoid structures in stage I lung adenocarcinoma
Xuejun Xu, Yifeng Gao, Shanzhou Duan, et al.
Cancer Medicine (2023) Vol. 12, Iss. 8, pp. 9547-9558
Open Access | Times Cited: 13
Immune Infiltration in Tumor and Adjacent Non-Neoplastic Regions Codetermines Patient Clinical Outcomes in Early-Stage Lung Cancer
Chao Cheng, Thinh T. Nguyen, Mabel Tang, et al.
Journal of Thoracic Oncology (2023) Vol. 18, Iss. 9, pp. 1184-1198
Closed Access | Times Cited: 12
Spatial transcriptomics reveals heterogeneity of histological subtypes between lepidic and acinar lung adenocarcinoma
Linshan Xie, Hui Kong, Jinjie Yu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 4
Model for predicting immunotherapy based on M2 macrophage infiltration in TNBC
Haoming Wu, Jikun Feng, Wenjing Zhong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Perioperative inflammatory index differences between pulmonary squamous cell carcinoma and adenocarcinoma and their prognostic implications
Yi Liu, Songping Cui, Jinglong Wang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Progression to invasive carcinoma: cellular activities and immune-related pathways define the lepidic and acinar subtypes of lung adenocarcinoma
Ethan N. Okoshi, Shiro Fujita, Kris Lami, et al.
Pathology (2025)
Closed Access
A nicotinamide metabolism-related gene signature for predicting immunotherapy response and prognosis in lung adenocarcinoma patients
Meng Wang, Li Wei, Fang Zhou, et al.
PeerJ (2025) Vol. 13, pp. e18991-e18991
Open Access
MOGAN for LUAD Subtype Classification by Integrating Three Omics Data Types
Haibin He, Longxing Wang, Ming-Yue Ma
Cancer Innovation (2025) Vol. 4, Iss. 2
Open Access
RFX2 downregulates RASSF1 expression and YAP phosphorylation through Hippo signaling to promote immune escape in lung adenocarcinoma
Zhenzhen Kong, Ping Zhou, Jiahao Xu, et al.
Cell Division (2025) Vol. 20, Iss. 1
Open Access
Exploring Target Genes in the miRNA-mRNA Regulatory Network of Lung Adenocarcinoma Based on Bioinformatics
刘梦 段
Journal of Clinical Personalized Medicine (2025) Vol. 04, Iss. 02, pp. 1196-1204
Open Access
The MYC/TXNIP axis mediates NCL-Suppressed CD8+T cell immune response in lung adenocarcinoma
Dan Xiao, Tanxiu Chen, Xinlin Yu, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Comparative profiling of single-cell transcriptome reveals heterogeneity of tumor microenvironment between solid and acinar lung adenocarcinoma
Dianke Li, Huansha Yu, Junjie Hu, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 13
ALKBH5 promotes the development of lung adenocarcinoma by regulating the polarization of M2 macrophages through CDCA4
Jianlong Tan, Fengyu Chen, Jufen Wang, et al.
Gene (2023) Vol. 895, pp. 147975-147975
Open Access | Times Cited: 8
Anlotinib and anti-PD-1 mAbs perfected CIK cell therapy for lung adenocarcinoma in preclinical trials
Yingge Lv, Hua Zhao, Shaochuan Liu, et al.
Journal of Leukocyte Biology (2024) Vol. 116, Iss. 3, pp. 544-554
Open Access | Times Cited: 2
First-line immunotherapy in non-small cell lung cancer: how to select and where to go
Andrea Mogavero, Ornella Cantale, Veronica Mollica, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 12, pp. 1191-1206
Closed Access | Times Cited: 5
Immune infiltration landscape on prognosis and therapeutic response and relevant epigenetic and transcriptomic mechanisms in lung adenocarcinoma
Liangming Zhang, Biwang Jiang, Zhuxiang Lan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
TTYH3, a potential prognosis biomarker associated with immune infiltration and immunotherapy response in lung cancer
Zimeng Wei, Xingruo Zeng, Yufei Lei, et al.
International Immunopharmacology (2022) Vol. 110, pp. 108999-108999
Closed Access | Times Cited: 8
High‑risk pathological subtype associated FAM83A‑AS1 promotes malignancy and glycolysis of lung adenocarcinoma via miR‑202‑3p/HK2 axis
Xinkui Xiong, Lei Zhang, Bao Zang, et al.
Oncology Reports (2023) Vol. 49, Iss. 5
Open Access | Times Cited: 4
Single-cell RNA sequencing reveals epithelial cells driving brain metastasis in lung adenocarcinoma
Yonghui Wu, Fujun Yang, Shilan Luo, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109258-109258
Open Access | Times Cited: 1
Lung adenocarcinoma: selection of surgical approaches in solid adenocarcinoma from the viewpoint of clinicopathologic features and tumor microenvironmental heterogeneity
Xiao Li, Zhen Gao, Haixiao Diao, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Predicting anti-cancer drug sensitivity through WRE-XGBoost algorithm with weighted feature selection
Yiyao Jiang, Ming Chen, Zhongmin Xiong, et al.
Genes & Diseases (2024) Vol. 12, Iss. 2, pp. 101275-101275
Open Access | Times Cited: 1
The impact of BTK knockdown on lung adenocarcinoma growth and immune response
Jennifer J. Huang, Yufan Yuan, Linghong Guo, et al.
Cancer Science (2024)
Closed Access | Times Cited: 1
GPR37-centered ceRNA network contributes to metastatic potential in lung adenocarcinoma: Evidence from high-throughput sequencing
Chuanhui Chen, Mengzhi Wan, Xiong Peng, et al.
Translational Oncology (2023) Vol. 39, pp. 101819-101819
Open Access | Times Cited: 3
Comprehensive analysis of the cuproptosis-related model to predict prognosis and indicate tumor immune infiltration in lung adenocarcinoma
Minle Wu, Jie Bao, Youfeng Lei, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top